Vision & Mission

The main purpose of Hera-MI is to use Artificial Intelligence (AI) to help early-stage breast cancer diagnosis in order to optimize patient care and save millions of women worldwide.

Our ambition is to speed up and improve breast cancer diagnosis thanks to the development of clinical decision support solutions.

Hera-MI has developed Breast-SlimView, a patented clinical decision support solution for 2D/3D mammography.

Breast Cancer

Artificial Intelligence

Mammography

Dedicated to radiologists and patients

Speed up and improve breast cancer diagnosis thanks to

Artificial Intelligence in order to save millions of women

Free yourselves from irrelevant information
and detect suspicious areas at a glance

Request a demo

Breast-SlimView offers an innovative and disruptive reading solution where only relevant information is displayed

News

Fujifilm & AI

Interview of Fujifilm France Marketing & Strategic Director

View more

Airbus & Hera-MI partnership

Hera-MI & Airbus partnership has been signed on April 30th 2019.

View more

Fujifilm & Hera-MI partnership

Fujifilm & Hera-MI become scientific and business partners

View more

A patented clinical decision solution
for 2D/3D mammography

Events

Meet us at tradeshows, conferences, and events.

 

Find more

Blog

Find scientific articles on Artificial Intelligence

in radiology and breast cancer

Find more

A faster and improved breast cancer diagnosis

Subscribe to our newsletter

Get more information and keep informed about Hera-MI and Breast-SlimView by subscribing to our newsletter.


Follow us